Form 4/A for MAIA MAIA Biotechnology, Inc.

Accepted 2025-03-05 00:00:00 ET · period of report 2025-02-24 · accession 0001127602-25-008317 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DA	2025-03-05	2025-02-24	MAIA	Guerrero Ramiro	Dir	P - Purchase	$1.50	+73.3K	534.9K	+16%	+$110.0K
DA	2025-03-05	2025-02-24	MAIA	Guerrero Ramiro	Dir	P - Purchase	$1.87	+73.3K	73.3K	New	+$137.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-02-24	P	A	73,333	$1.50	534,885.04	D	—	—	(F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plna on February 24, 2025.
2	Derivative	Warrants	2025-02-24	P	A	73,333	$1.87	73,333	D	$1.87 · 2026-02-25 to 2031-02-25	73,333 Common Stock	(F2) This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 2 to "February 24, 2025". (F3) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.